385 related articles for article (PubMed ID: 37511248)
1. The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer.
Bogaczyk A; Zawlik I; Zuzak T; Kluz M; Potocka N; Kluz T
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511248
[TBL] [Abstract][Full Text] [Related]
2. [The role of miRNA in endometrial cancer in the context of miRNA 205].
Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
[TBL] [Abstract][Full Text] [Related]
3. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive miRNA profiling of surgically staged endometrial cancer.
Cohn DE; Fabbri M; Valeri N; Alder H; Ivanov I; Liu CG; Croce CM; Resnick KE
Am J Obstet Gynecol; 2010 Jun; 202(6):656.e1-8. PubMed ID: 20400061
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.
Sianou A; Galyfos G; Moragianni D; Andromidas P; Kaparos G; Baka S; Kouskouni E
Arch Gynecol Obstet; 2015 Aug; 292(2):271-82. PubMed ID: 25697925
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.
Kontomanolis EN; Koukourakis MI
Microrna; 2015; 4(1):18-25. PubMed ID: 26088599
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
Boren T; Xiong Y; Hakam A; Wenham R; Apte S; Wei Z; Kamath S; Chen DT; Dressman H; Lancaster JM
Gynecol Oncol; 2008 Aug; 110(2):206-15. PubMed ID: 18499237
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in endometrial cancer.
Banno K; Yanokura M; Kisu I; Yamagami W; Susumu N; Aoki D
Int J Clin Oncol; 2013 Apr; 18(2):186-92. PubMed ID: 23380959
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Oncogenic and Tumor-Suppressing miRNA Types in Egyptian Uterine Cancer Patients.
Salim EI; Beltagy DM; Elmashad NM; Abodonia MA
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2607-2615. PubMed ID: 36037113
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
18. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and their role in environmental chemical carcinogenesis.
Li M; Huo X; Davuljigari CB; Dai Q; Xu X
Environ Geochem Health; 2019 Feb; 41(1):225-247. PubMed ID: 30171477
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as potential biomarkers for gastric cancer.
Liu HS; Xiao HS
World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
